Related Experiment Video
Updated: May 18, 2026
07:55
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Control of amyloid assembly by autoregulation
Michael Landreh1, Jan Johansson, Anna Rising
1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden.
The Biochemical Journal
|September 28, 2012
Summary
Proteins self-regulate amyloid fibril assembly, crucial for both health and disease. This review details molecular mechanisms proteins use to control their own fibrillation, ensuring proper function and preventing harmful aggregation.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Protein aggregation into amyloid fibrils is implicated in diseases and functional biological processes.
- Tight control over protein self-assembly is essential to prevent aberrant aggregation.
- Proteins often employ self-chaperoning mechanisms to limit the conformational flexibility of amyloidogenic segments.
Purpose of the Study:
- To review the diverse molecular mechanisms proteins utilize for self-regulation of amyloid fibril assembly.
- To highlight how these autoregulatory elements control both disease-related and functional amyloids.
- To identify a common theme of self-regulating amyloids across various biological contexts.
Main Methods:
- Literature review of molecular mechanisms controlling protein self-assembly into fibrils.
- Analysis of autoregulatory strategies employed by proteins.
- Categorization of self-regulating amyloid systems based on biological function and organism.
Main Results:
- Proteins utilize strategies like chaperoning domains, blocking segments in proforms, controlled release of amyloidogenic regions, and pH-dependent fibrillation control.
- These autoregulatory mechanisms are effective in managing both pathological and physiological protein aggregation.
- Self-regulating amyloids represent a conserved principle across diverse biological functions and organisms.
Conclusions:
- Proteins possess intrinsic molecular mechanisms to control their own amyloid formation.
- These self-regulatory strategies are vital for maintaining protein homeostasis and preventing aggregation-related pathologies.
- Understanding these mechanisms provides insights into both disease etiology and the function of amyloid structures in biology.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:17Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...